Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails

References

• Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011;134:522–531.
   PubMedGoogle Scholar
• Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146. doi: 10.1056/NEJMra050436
   PubMed Web of Science ®Google Scholar
• Kalpravidh RW, Siritanaratkul N, Insain P, et al. Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem. 2010;43(4-5):424–429. doi: 10.1016/j.clinbiochem.2009.10.057
   PubMed Web of Science ®Google Scholar
• Ozdemir ZC, Koc A, Aycicek A, et al. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia. Hemoglobin. 2014;38(5):359–364. doi: 10.3109/03630269.2014.951890
   PubMed Web of Science ®Google Scholar
• Tesoriere L, D'Arpa D, Butera D, et al. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia intermedia patients. Free Radic Res. 2001;34(5):529–540. doi: 10.1080/10715760100300461
   PubMed Web of Science ®Google Scholar
• Elalfy MS, Adly AA, Attia AA, et al. Effect of antioxidant Therapy on Hepatic Fibrosis and Liver iron concentrations in β-thalassemia major patients. Hemoglobin. 2013;37(3):257–276. doi: 10.3109/03630269.2013.778866
   PubMed Web of Science ®Google Scholar
• Yanpanitch OU, Hatairaktham S, Charoensakdi R, et al. Treatment of beta-thalassemia/hemoglobin E with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and Improvement of the hypercoagulable state. Oxid Med Cell Longev. 2015;2015:537954), doi: 10.1155/2015/537954
   PubMed Web of Science ®Google Scholar
• Hagag AA, Elfaragy MS, Elrifaey SM, et al.[CDATA[therapeutic value of combined therapy with deferiprone and Silymarin as iron chelators in Egyptian Children with Beta thalassemia major]]. Infect Disord Drug Targets. 2015;15(3):189–195. doi: 10.2174/1871526515666150731113305
   PubMedGoogle Scholar
• Hashiguchi A, Tian J, Komatsu S. Proteomic contributions to medicinal plant research: from plant metabolism to pharmacological action. Proteomes. 2017;5(4):35), doi: 10.3390/proteomes5040035
   Web of Science ®Google Scholar
• Guerranti R, Ogueli IG, Bertocci E, et al. Proteomic analysis of the pathophysiological process involved in the antisnake venom effect ofMucuna pruriens extract. Proteomics. 2008;8(2):402–412. doi: 10.1002/pmic.200700265
   PubMed Web of Science ®Google Scholar
• Li R, Zhao L, Wu N, et al. Proteomic analysis allows for identifying targets of Yinchenwuling powder in hyperlipidemic rats. J Ethnopharmacol. 2016;185:60–67. doi: 10.1016/j.jep.2016.03.029
   PubMed Web of Science ®Google Scholar
• Weeraphan C, Srisomsap C, Chokchaichamnankit D, et al. Role of curcuminoids in ameliorating oxidative modification in β-thalassemia/Hb E plasma proteome. J Nutr Biochem. 2013;24(3):578–585. doi: 10.1016/j.jnutbio.2012.02.008
   PubMed Web of Science ®Google Scholar
• Sihlbom C, Kanmert I, Bahr H, et al. Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins. J Proteome Res. 2008;7(9):4191–4198. doi: 10.1021/pr800340c
   PubMed Web of Science ®Google Scholar
• Millioni R, Tolin S, Puricelli L, et al. High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity. PLoS One. 2011;6(5):e19603), doi: 10.1371/journal.pone.0019603
   PubMed Web of Science ®Google Scholar
• Voskou S, Aslan M, Fanis P, et al. Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biol. 2015;6:226–239. doi: 10.1016/j.redox.2015.07.018
   PubMed Web of Science ®Google Scholar
• Chapin J, Terry HS, Kleinert D, et al. The role of complement activation in thrombosis and hemolytic anemias. Transfus Apher Sci. 2016;54(2):191–198. doi: 10.1016/j.transci.2016.04.008
   PubMed Web of Science ®Google Scholar
• Taher AT, Otrock ZK, Uthman I, et al. Thalassemia and hypercoagulability. Blood Rev. 2008;22(5):283–292. doi: 10.1016/j.blre.2008.04.001
   PubMed Web of Science ®Google Scholar
• Malasit P, Mahasorn W, Mongkolsapaya J, et al. Presence of immunoglobulins, C3 and cytolytic C5b-9 complement components on the surface of erythrocytes from patients with?-thalassaemia/HbE disease. Br J Haematol. 1997;96(3):507–513. doi: 10.1046/j.1365-2141.1997.d01-2070.x
   PubMed Web of Science ®Google Scholar
• Yang J, Ahn HN, Chang M, et al. Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice. J Neurochem. 2013;124(4):523–535. doi: 10.1111/jnc.12111
   PubMed Web of Science ®Google Scholar
• Kulkarni AP, Ghebremariam YT, Kotwal GJ. Curcumin inhibits the classical and the alternate pathways of complement activation. Ann N Y Acad Sci. 2005;1056:100–112. doi: 10.1196/annals.1352.007
   PubMed Web of Science ®Google Scholar
• Perricone C, De Carolis C, Giacomelli R, et al. Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications. Int J Immunopathol Pharmacol. 2011;24(1):63–68. doi: 10.1177/039463201102400108
   PubMed Web of Science ®Google Scholar
• Sheehan M, Morris CA, Pussell BA, et al. Complement inhibition by human vitronectin involves non-heparin binding domains. Clin Exp Immunol. 1995;101(1):136–141. doi: 10.1111/j.1365-2249.1995.tb02289.x
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B. Clinical Applications of Hemolytic Markers in the differential Diagnosis and Management of Hemolytic anemia. Dis Markers. 2015;2015:635670), doi: 10.1155/2015/635670
   PubMed Web of Science ®Google Scholar
• Kopp A, Hebecker M, Svobodova E, et al. Factor h: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules. 2012;2(1):46–75. doi: 10.3390/biom2010046
   PubMedGoogle Scholar
• Ermert D, Blom AM. C4b-binding protein: The good, the bad and the deadly. novel functions of an old friend. Immunol Lett. 2016;169:82–92. doi: 10.1016/j.imlet.2015.11.014
   PubMed Web of Science ®Google Scholar
• Al-Quobaili FA, Abou Asali IE. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major. Saudi Med J. 2004;25(7):871–875.
   PubMed Web of Science ®Google Scholar
• Boudrahem-Addour N, Izem-Meziane M, Bouguerra K, et al. Oxidative Status and plasma lipid profile in β-thalassemia patients. Hemoglobin. 2015;39(1):36–41. doi: 10.3109/03630269.2014.979997
   PubMed Web of Science ®Google Scholar
• Ghorban K, Shanaki M, Mobarra N, et al. Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major. Hematology. 2016;21(2):113–120. doi: 10.1179/1607845415Y.0000000016
   PubMed Web of Science ®Google Scholar
• Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66(9):616–623. doi: 10.1002/iub.1314
   PubMed Web of Science ®Google Scholar
• Chaichompoo P, Kumya P, Khowawisetsut L, et al. Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients. J Proteomics. 2012;76 Spec No.:239–250. doi: 10.1016/j.jprot.2012.06.004
   PubMed Web of Science ®Google Scholar
• Podrez EA. Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol. 2010;37(7):719–725. doi: 10.1111/j.1440-1681.2010.05380.x
   PubMed Web of Science ®Google Scholar
• Shin SK, Ha TY, McGregor RA, et al. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res. 2011;55(12):1829–1840. doi: 10.1002/mnfr.201100440
   PubMed Web of Science ®Google Scholar
• Kaga E, Karademir B, Baykal AT, et al. Identification of differentially expressed proteins in atherosclerotic aorta and effect of vitamin E. J Proteomics. 2013;92:260–273. doi: 10.1016/j.jprot.2013.06.015
   PubMed Web of Science ®Google Scholar
• Zohaib M, Ansari SH, Hashim Z, et al. Serum paraoxonase activity and Malondialdehyde serum concentrations remain unaffected in response to Hydroxyurea therapy in beta-thalassemia patients. J Clin Pharmacol. 2016;56(7):869–874. doi: 10.1002/jcph.675
   PubMed Web of Science ®Google Scholar
• Selek S, Aslan M, Horoz M, et al. Oxidative status and serum PON1 activity in beta-thalassemia minor. Clin Biochem. 2007;40(5–6):287–291. doi: 10.1016/j.clinbiochem.2006.10.028
   PubMed Web of Science ®Google Scholar
• Labib HA, Etewa RL, Gaber OA, et al. Paraoxonase-1 and oxidative status in common Mediterranean β-thalassaemia mutations trait, and their relations to atherosclerosis. J Clin Pathol. 2011;64(5):437–442. doi: 10.1136/jcp.2011.090209
   PubMed Web of Science ®Google Scholar
• Morales N P, Cherlermchoung C, Fucharoen S, et al. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients. Clin Chem Lab Med. 2007;45(7):884–889.
   PubMed Web of Science ®Google Scholar
• Varatharajalu R, Garige M, Leckey LC, et al. Protective role of dietary curcumin in the prevention of the oxidative stress induced by chronic alcohol with respect to hepatic injury and antiatherogenic markers. Oxid Med Cell Longev. 2016;2016:5017460), doi: 10.1155/2016/5017460
   PubMed Web of Science ®Google Scholar
• Bierl C, Voetsch B, Jin RC, et al. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem. 2004;279(26):26839–26845. doi: 10.1074/jbc.M401907200
   PubMed Web of Science ®Google Scholar
• Hybertson BM, Gao B, Bose SK, et al. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011;32(4–6):234–246. doi: 10.1016/j.mam.2011.10.006
   PubMed Web of Science ®Google Scholar
• Bartfay WJ, Bartfay E. Selenium and glutathione peroxidase with beta-thalassemia major. Nurs Res. 2001;50(3):178–183. doi: 10.1097/00006199-200105000-00009
   PubMed Web of Science ®Google Scholar
• Rashidi M, Aboomardani M, Rafraf M, et al. Effects of vitamin E and zinc supplementation on antioxidants in beta thalassemia major patients. Iran J Pediatr. 2011;21(1):8–14.
   PubMed Web of Science ®Google Scholar